TY - JOUR
T1 - EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI)
T2 - development of a consensus patient index for primary Sjogren's syndrome
AU - Seror, Raphaele
AU - Ravaud, Philippe
AU - Mariette, Xavier
AU - Bootsma, Hendrika
AU - Theander, Elke
AU - Hansen, Arne
AU - Ramos-Casals, Manel
AU - Doerner, Thomas
AU - Bombardieri, Stefano
AU - Hachulla, Eric
AU - Brun, Johan G.
AU - Kruize, Aike A.
AU - Praprotnik, Sonja
AU - Tomsic, Matija
AU - Gottenberg, Jacques-Eric
AU - Devauchelle, Valerie
AU - Devita, Salvatore
AU - Vollenweider, Cristina
AU - Mandl, Thomas
AU - Tzioufas, Athanasios
AU - Carsons, Steven
AU - Saraux, Alain
AU - Sutcliffe, Nurhan
AU - Vitali, Claudio
AU - Bowman, Simon J.
AU - EULAR Sjogren's Task Force
PY - 2011/6
Y1 - 2011/6
N2 - Objectives To develop a score for assessment of patients' symptoms in primary Sjogren's syndrome (SS): the EULAR SS Patient Reported Index (ESSPRI).Methods Dryness, pain, somatic and mental fatigue were identified as the main symptoms of patients with primary SS, in studies developing the Profile of Fatigue and Discomfort (PROFAD) and Sicca Symptoms Inventory (SSI). It was suspected that a single 0-10 numerical scale for each domain was sufficient to assess these symptoms. These four scales were gathered to form the ESSPRI. 230 patients, from 12 countries completed the ESSPRI, SSI and PROFAD questionnaires and a 0-10 patient global assessment (PGA). Correlations between each symptom and PGA were obtained. Multiple regression modelling, using PGA as 'gold standard' was used to select domains and estimate their weights.Results PGA had good correlation with dryness, limb pain, fatigue and mental fatigue (r=0.49-0.59, all pConclusion ESSPRI is a very simple index designed to measure patients' symptoms in primary SS. It has good construct validity and is well correlated with SSI and PROFAD. ESSPRI should now be validated for use as an outcome measure in clinical trials.
AB - Objectives To develop a score for assessment of patients' symptoms in primary Sjogren's syndrome (SS): the EULAR SS Patient Reported Index (ESSPRI).Methods Dryness, pain, somatic and mental fatigue were identified as the main symptoms of patients with primary SS, in studies developing the Profile of Fatigue and Discomfort (PROFAD) and Sicca Symptoms Inventory (SSI). It was suspected that a single 0-10 numerical scale for each domain was sufficient to assess these symptoms. These four scales were gathered to form the ESSPRI. 230 patients, from 12 countries completed the ESSPRI, SSI and PROFAD questionnaires and a 0-10 patient global assessment (PGA). Correlations between each symptom and PGA were obtained. Multiple regression modelling, using PGA as 'gold standard' was used to select domains and estimate their weights.Results PGA had good correlation with dryness, limb pain, fatigue and mental fatigue (r=0.49-0.59, all pConclusion ESSPRI is a very simple index designed to measure patients' symptoms in primary SS. It has good construct validity and is well correlated with SSI and PROFAD. ESSPRI should now be validated for use as an outcome measure in clinical trials.
KW - PLACEBO-CONTROLLED TRIAL
KW - PRIMARY SJGRENS-SYNDROME
KW - RITUXIMAB TREATMENT
KW - DISEASE-ACTIVITY
KW - DOUBLE-BLIND
KW - SYMPTOMS INVENTORY
KW - CLINICAL-TRIALS
KW - DAMAGE INDEX
KW - DRY MOUTH
KW - VALIDATION
U2 - 10.1136/ard.2010.143743
DO - 10.1136/ard.2010.143743
M3 - Article
SN - 0003-4967
VL - 70
SP - 968
EP - 972
JO - Annals of the Rheumatic Diseases
JF - Annals of the Rheumatic Diseases
IS - 6
ER -